Population pharmacokinetics of tipifarnib in healthy subjects and adult cancer patients

Por Perez-Ruixo, Juan Jose, Piotrovskij, Vladimir, Zhang, Steven, Hayes, Siobhan, Porre, Peter De, Zannikos, Peter
Publicado em 2006

The roles of CYP2D6 and stereoselectivity in the clinical pharmacokinetics of chlorpheniramine

Por Yasuda, Sally Usdin, Zannikos, Peter, Young, Andrea E, Fried, Karen M, Wainer, Irving W, Woosley, Raymond L
Publicado em 2002

A Phase I Trial and Pharmacokinetic Study of a 24-hour Infusion of Trabectedin (Yondelis®, ET-743) in Children and Adolescents with Relapsed or Refractory Solid Tumors

Por Chuk, Meredith K., Aikin, Alberta, Whitcomb, Trish, Widemann, Brigitte C., Zannikos, Peter, Bayever, Eliel, Balis, Frank M., Fox, Elizabeth
Publicado em 2012

Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors

Por Messersmith, Wells A., Jimeno, Antonio, Ettinger, David, Laheru, Dan, Brahmer, Julie, Lansey, Dina, Khan, Yasmin, Donehower, Ross C., Elsayed, Yusri, Zannikos, Peter, Hidalgo, Manuel
Publicado em 2008

Phase 1 Trial and Pharmacokinetic Study of the Farnesyl Transferase Inhibitor Tipifarnib in Children and Adolescents with Refractory Leukemias: A Report from the Children's Oncolog...

Por Widemann, Brigitte C., Arceci, Robert J., Jayaprakash, Nalini, Fox, Elizabeth, Zannikos, Peter, Goodspeed, Wendy, Goodwin, Anne, Wright, John J., Blaney, Susan M., Adamson, Peter C., Balis, Frank M.
Publicado em 2010

Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma

Por Reece, Donna E., Sullivan, Dan, Lonial, Sagar, Mohrbacher, Ann F., Chatta, Gurkamal, Shustik, Chaim, Burris, Howard, Venkatakrishnan, Karthik, Neuwirth, Rachel, Riordan, William J., Karol, Michael, von Moltke, Lisa L., Acharya, Milin, Zannikos, Peter, Stewart, A. Keith
Publicado em 2010